180 Life Sciences Corp. Announces $425 Million Private Placement to Establish Ethereum Treasury and Rebrand as ETHZilla
180 Life Sciences Corp. has announced a $425 million private investment in public equity $(PIPE)$ transaction to enhance its treasury reserve with Ether, the native digital asset of Ethereum. The transaction, expected to close around August 1, 2025, involves the sale of common stock and possibly pre-funded warrants, with investors being granted registration rights. Following the closing, the company plans to rebrand as ETHZilla Corporation. Additionally, 180 Life Sciences has approval to sell up to $150 million in debt securities, which it plans to offer after the PIPE transaction. Clear Street LLC served as the financial advisor and exclusive placement agent for the offering.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 180 Life Sciences Corp. published the original content used to generate this news brief via PR Newswire (Ref. ID: NY39651) on July 29, 2025, and is solely responsible for the information contained therein.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。